5-Aminolevulinic Acid-Mediated Photodynamic Therapy Can Target Aggressive Adult T Cell Leukemia/Lymphoma Resistant to Conventional Chemotherapy

With 16 primary blood samples from 13 patients, researchers demonstrated that photodynamic therapy efficiently killed tumor cells without influencing normal lymphocytes in aggressive diseases such as acute adult T cell leukemia/lymphoma.
[Scientific Reports]
Sando, Y., Matsuoka, K., Sumii, Y., Kondo, T., Ikegawa, S., Sugiura, H., Nakamura, M., Iwamoto, M., Meguri, Y., Asada, N., Ennishi, D., Nishimori, H., Fujii, K., Fujii, N., Utsunomiya, A., Oka, T., & Maeda, Y. (2020). 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Scientific Reports, 10(1), 17237. https://doi.org/10.1038/s41598-020-74174-x Cite
Full Article
Bookmark

No account yet? Register

0
Share

Increased Baseline RASGRP1 Signals Enhance Stem Cell Fitness during Native Hematopoiesis

The authors expanded RASGRP1 expression surveys in pediatric T-ALL and generated a RoLoRiG mouse model crossed to Mx1CRE to determine the consequences of induced RASGRP1 overexpression in primary hematopoietic cells.
[Oncogene]
Karra, L., Romero-Moya, D., Ksionda, O., Krush, M., Gu, Z., Mues, M., Depeille, P., Mullighan, C., & Roose, J. P. (2020). Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis. Oncogene, 1–15. https://doi.org/10.1038/s41388-020-01469-8 Cite
Abstract
Bookmark

No account yet? Register

0
Share

GvHD-Free, Relapse-Free Survival Provides Novel Clues for Optimizing Allogeneic-HSCT for Adult T-Cell Leukemia/Lymphoma

The authors performed a nationwide retrospective study of graft-versus-host disease (GvHD)-free, relapse-free survival of patients with allogeneic hematopoietic stem cell transplantation (HSCT)-treated adult T-cell leukemia/lymphoma.
[Bone Marrow Transplantation]
Muranushi, H., Shindo, T., Hishizawa, M., Tokunaga, M., Wake, A., Nakano, N., Eto, T., Hidaka, M., Choi, I., Miyamoto, T., Uchida, N., Moriuchi, Y., Miyazaki, Y., Fukuda, T., Ichinohe, T., Atsuta, Y., & Kato, K. (2020). GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma. Bone Marrow Transplantation, 1–12. https://doi.org/10.1038/s41409-020-00996-y Cite
Abstract
Bookmark

No account yet? Register

0
Share
Share